Bruno_nervi.jpg_thumb90

Bruno Nervi Nattero

Associated Professor

Pontificia Universidad Catolica de Chile

Santiago, Chile

Líneas de Investigación


1. Cancer interaction with the microenvironment 2. Acute myeloid leukemia progression and resistance to treatment modulated by the bone marrow stroma 2. Gallbladder cancer progression and resistance to treatment modulated by the tumor stroma

Educación

  •  Medico Cirujano, PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE. Chile, 1996
  •  Internal Medicine, PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE. Chile, 1998
  •  Sub-specialty Hematology and Oncology, PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE. Chile, 2002
  •  Sub-specialty Hematology - Oncology, WASHINGTON UNIVERSITY SCHOOL OF MEDICINE. Estados Unidos, 2006

Experiencia Académica

  •   Assistant Professor Full Time

    PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

    Faculty of Medicine

    Santiago, Chile

    2009 - 2015

  •   Chief UC Medical Oncology Full Time

    PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

    Faculty of Medicine

    Santiago, Chile

    2011 - 2015

  •   Instructor in Medicine Full Time

    PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

    Faculty of Medicine

    Santiago, Chile

    2002 - 2008

  •   Associated Professor Full Time

    PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

    Faculty of Medicine

    Santiago, Chile

    2015 - A la fecha

  •   Chief Medical Oncology Programme Full Time

    PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

    Faculty of Medicine

    Santiago, Chile

    2009 - A la fecha

  •   Chief Hematology-Oncology Department Full Time

    PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

    Medicine

    Santiago, Chile

    2022 - A la fecha

Experiencia Profesional

  •   Instructor of Medicine Full Time

    Pontificia Universidad Catolica de Chile

    Santiago, Chile

    2002 - 2009

  •   Associated Professor Full Time

    Pontificia Universidad Catolica de Chile

    Santiago, Chile

    2015 - A la fecha

  •   Assistant Professor Full Time

    Pontificia Universidad Catolica

    Santiago, Chile

    2009 - 2015

  •   Medical Director of the UC Cancer Center Full Time

    Red de Salud UC-CHRISTUS

    Santiago, Chile

    2017 - 2021

Formación de Capital Humano


Undergraduate and postgraduate students:
1. Francisco Barriga, Biochemistry, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile. Thesis: "The Interaction with bone marrow stroma protects leukemia cells from therapy-induced apoptosis", 2009.
2. Maria del Pilar Swett, Biochemistry, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile. Thesis: "The bone marrow stroma cells protects acute myeloid leukemia cells from Cytarabine induced apoptosis by modulation of human equilibrative nucleoside transporter", 2013-2014.
3. Antonella Rosati, MSc Biologia Molecular, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile. Thesis: "La transición mesenquimal es uno de los mecanismos de resistencia a la quimioterapia de leucemia mieloide aguda conferidos por el estroma", 2015-2016.
4. Macarena Tobar Tobar, Biochemistry, Facultad de Química y Biología, Universidad de Santiago. Thesis: "Bone marrow stroma cells confer resistance to acute myeloid leukemia cellls through the activation of tyrosine kinase and mTOR interacellular signaling", 2019-2020.

Biochemistry and Biology students:
1. Francisco Leisewitz, Universidad Andres Bello, 2010
2. Victoria Gidi, Pontificia Universidad Católica de Chile, 2011
3. Alejandra Guzmán, Pontificia Universidad Católica de Chile, 2012
4. María Ignacia García Vargas, Facultad de Ciencias Biológicas, Universidad Católica de Chile, 2019-2020.


Difusión y Transferencia


Public Health Activities:
1. President of the Chilesincancer Foundation (www.chilesincancer.cl) (2015 to present).
Our mission is to generate the best conditions of infrastructure, human capital and management for the care of patients with cancer in Chile, and our purpose is that all Chileans have timely and quality cancer care.
2. President of the Advisory Council in matters of cancer (2018-2021).
This council incorporated experts from scientific societies, universities and foundations dedicated to cancer, to collaborate with
the Ministry of Health in the drafting and implementation of the National Cancer Plan 2018-2028.
3. Cancer Advisor to the Ministry of Health (2020-2021).
The objective was to collaborate for the implementation of the Cancer Law that was enacted by October 2020, favoring the participation of
civil society. Tha Cancer Law was promoted by former senator Carolina Goic, who currently has an academic appointment at the Universidad Católica de Chile, and Dr. Nervi played an active and
participative role from the University to contribute to the approval of the Law.
4. President of the National Cancer Commission (2021 to present).
The comission has 11 representatives of civil society that include 5 of the 19 presidents of scientific societies, 3 representatives of the 29 medical schools, and 3 representatives of the 40 patient groups and foundations. The mission of this commission is to advise the Ministry of Health in the implementation of the national cancer plan. It
will also support the management of competitive contests for training, research, prevention or care projects for cancer patients, who will apply for the cancer law fund.

Poster Presentations:
1. "The bone marrow stroma as a novel prognostic factor for patients with acute myeloid leukaemia". Patricia Macanas-Pirard, Richard Broekhuizen, Sergio Vargas-Salas, Romina Coronado, Carolina Bizama, Sabrina Muñiz-Muñoz, Oslando Padilla, Viviana Montecinos, Juan Carlos Roa and Bruno Nervi. . The virtual congress on controversies in leukemias. #21. Euroleuk2020.

2. The bone marrow stroma capacity to confer resistance to leukemia cells from Ara-C treatment as a prognostic factor for overall survival in AML. Patricia Macanas-Pirard, Sergio Vargas-Salas, Richard Broekhuizen, Romina Coronado, Carolina Bizama, Sabrina Muñiz-Muñoz, Vivianne Torres, Viviana Montecinos, Daniel Ernst, Francisco Melo, Juan Carlos Roa, Bruno Nervi. J Clin Oncol 37, 2019 (abstr e18500). DOI: 10.1200/JCO.2019.37.15_suppl.e18500. ASCO anual meeting.

3. “Nuevas estrategias para el tratamiento del cáncer de vesícula biliar mediante la modulación de la interacción entre microambiente y cáncer” Nervi Bruno, Macanás Patricia, Broekhuizen Richard, Swett Pilar, Ramírez Pablo, Leisewitz Andrea. Viña del Mar, Chile, 2012.

2. “Bone marrow stoma secretes a soluble factor that protects leukemia cells from cytarabine induced apoptosis by blocking ent activity” Patricia Macanás, PhD, Andrea Leisewitz, PhD, Richard Broekhuizen, Victoria Chomali, Francisco Leisewitz, Pablo Ramirez, MD, Kelly Cautivo, Alexis Kalergis, PhD, John F DiPersio, MD PhD and Bruno Nervi. Honolulu, Hawai, USA, 2011.

3. “Impacto del tipo de donante en los resultados de trasplante alogenico de precursores hematopoyéticos en niños con neoplasias hematológicas” Rojas N, Wietstruck MA, Zúñiga P, Silva A, Nervi B, Barriga F. XVII Congreso Chileno de Hematología, Coquimbo, Chile, 2010.

4. “Resistance to AraC involves ERK signaling pathway and hENT1 activity down regulation in leukemic cells”. Richard A.J.F. Broekhuizen, Patricia Macanas, Andrea V. Leisewitz, Bruno Nervi. Congreso Anual de la Sociedad Chilena de Biología, Pucón, Chile, 2010.

5. “Células estromales de la medula ósea secretan un factor soluble que protege a células leucémicas de muerte inducida por quimioterapia” Leisewitz F.J., Macanas P., Besa P., Riquelme E., Kalergis A., Leisewitz A.V. y Nervi B. Congreso Anual de la Sociedad Chilena de Biología, Pucón, Chile, 2009.

6. “The interaction between leukemia and bone marrow stroma protects the tumor cells from chemotherapy- and radiotherapy-induced apoptosis”. Francisco Barriga, Erick Riquelme, Patricia Macanás, Pelayo Besa, Richard Broekhuizen, John F DiPersio, Alexis Kalergis and Bruno Nervi. Bone Marrow Transplantation Tandem Meeting, Tampa, USA, 2009.

Undergraduate teaching
1. Responsible for the Oncology chapter, Fisiopathology course, Faculty of Medicine, Medicine third year students.
2. Responsible for the Oncology chapter, Fisiopathology course, Faculty of Medicine, Odontology third year students.
3. Lectures in the Faculty of Biological Sciences and Medicine: "Leukemia", "The interaction between cancer cells and their stroma", "Stem cell transplantation", "


Premios y Distinciones

  •   Best Scientific Award

    Congreso Chileno de Cancerologia

    Chile, 2012

    Best Scientific Award for the best presented project at the Congreso Chileno de Cancerologia 2012.

  •   Junior Clinical Excellence Award

    PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

    Chile, 2011

    I received a recognition Award for my clinical achievements at my Institution, the Pontificia Universidad Catolica de Chile, Faculty of Medicine.


 

Article (46)

Liver transplantation for non-resectable colorectal liver metastases: A review
SARS-CoV-2 vaccine booster in solid organ transplant recipients previously immunised with inactivated versus mRNA vaccines: A prospective cohort study
Biliary Tract Cancer
Early versus deferred anti-SARS-CoV-2 convalescent plasma in patients admitted for COVID-19: A randomized phase II clinical trial
Estimating the impact of the COVID-19 pandemic on diagnosis and survival of five cancers in Chile from 2020 to 2030: a simulation-based analysis
A Molecular Stratification of Chilean Gastric Cancer Patients with Potential Clinical Applicability
Complete Response to Immunotherapy Plus Chemotherapy After an Unusual Clinical Response to Afatinib and Stereotactic Radiosurgery in a Patient With Metastatic EGFR-Mutant Non-Small-Cell Lung Cancer
First-line endocrine therapy for advanced breast cancer. A real-world study at a Latin American university health institution
Hippo-YAP1 Is a Prognosis Marker and Potentially Targetable Pathway in Advanced Gallbladder Cancer
Metformin protects from oxaliplatin induced peripheral neuropathy in rats
Retrospective Analysis of Chilean and Mexican GI Stromal Tumor Registries: A Tale of Two Latin American Realities
Biliary tract cancer prognostic and predictive genomics
Chilean Registry for Neuroendocrine Tumors=> A Latin American Perspective.
Evaluation and management of incidental gallbladder cancer
High Proportion of Potential Candidates for Immunotherapy in a Chilean Cohort of Gastric Cancer Patients: Results of the FORCE1 Study
Prevalence of EGFR Mutations and Clinico-Pathological Characteristics of Chilean Lung Cancer Patients
Mortality of Adult Patients With Cancer Admitted to an Intensive Care Unit in Chile: A Prospective Cohort Study
Regorafenib adjusted dose for Chilean patients with chemoresistant metastatic colorectal cancer: a case series
Resistance of leukemia cells to cytarabine chemotherapy is mediated by bone marrow stroma, involves cell-surface equilibrative nucleoside transporter-1 removal and correlates with patient outcome
The CCL2/CCR2 Axis Affects Transmigration and Proliferation but Not Resistance to Chemotherapy of Acute Myeloid Leukemia Cells
Beneficio de la quimioterapia adyuvante en pacientes con cáncer de colon: cohorte retrospectiva de un hospital clínico universitario
Central nervous system metastasis secondary to colorectal cancer: a retrospective cohort study of 20 cases
Low expression of equilibrative nucleoside transporter 1 is associated with poor prognosis in chemotherapy-naïve pT2 gallbladder adenocarcinoma patients
A snapshot of cancer in Chile: analytical frameworks for developing a cancer policy.
Admission of Hematopoietic Cell Transplantation Patients to the Intensive Care Unit at the Pontificia Universidad Catolica de Chile Hospital
Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy
Rapamycin and WYE-354 suppress human gallbladder cancer xenografts in mice
Endovascular treatment of aorto-esophageal fistula due to esophageal cancer. Report of one case
The immunological response and post-treatment survival of DC-vaccinated melanoma patients are associated with increased Th1/Th17 and reduced Th3 cytokine responses
Umbilical Cord Blood Transplantation in Hematologic Diseases in Patients Over 15 Years Old: Long-term Experience at the Pontificia Universidad Catolica de Chile
Bone Marrow Stromal Cells Modulate Mouse ENT1 Activity and Protect Leukemia Cells from Cytarabine Induced Apoptosis
Profilaxis de citomegalovirus en niños y adultos sometidos a trasplante de órganos sólidos y de precursores hematopoyéticos
Prophylaxis against cytomegalovirus infection in pediatric and adult patients undergoing solid organ and hematopoietic stem cells transplantation
Thalidomide for the treatment of metastatic hepatic epithelioid hemangioendothelioma: A case report with a long term follow-up
Búsqueda de mutaciones en el gen UL 97 asociadas a resistencia a ganciclovir en citomegalovirus obtenidos desde muestras biológicas de pacientes chilenos
Presence of mutations associated with ganciclovir resistance in cytomegalovirus UL97 gene [Búsqueda de mutaciones en el gen UL 97 asociadas a resistencia a ganciclovir en citomegalovirus obtenidos desde muestras biológicas de pacientes chilenos]
Presence of mutations associated with gancicloyir resistance in cytomegalovirus UL97 gene
Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100
Hepatectomy for cholangiocarcinoma in one patient with Dubin Johnson syndrome
Invasive fungal disease in hemato-oncological and hematopoietic stem cell transplantation patients from Hospital Clinico Universidad Catolica, Santiago-Chile using revised EORTC/MSG diagnostic criteria
THE INTERACTION BETWEEN LEUKEMIA AND BONE MARROW STROMA PROTECTS THE TUMOR CELLS FROM CHEMOTHERAPY- AND RADIOTHERAPY-INDUCED APOPTOSIS
Umbilical cord hematopoietic precursors transplantation. Report of five patients
AMD3100: CXCR4 antagonist and rapid stem cell-mobilizing agent
Nuevas alternativas en el tratamiento del cancer gástrico avanzado
Treatment of advanced gastric cancer with oxaliplatin plus 5-fluorouracil/leucovorin (FOLFOX-4 chemotherapy)
Symptom Control and Palliative Care in Chile

Abstract (7)

Allogeneic Hematopoietic Stem Cell Transplantation (aHSCT) In Adult Patients With Acute Lymphoblastic Leukemia (ALL): Experience Of The Hematology-Oncology Department At Pontificia Universidad Catolica De Chile Between 1994 and 2013
Critical Care Unit Admission Of Hematopoietic Stem Cell Transplant Patients In An University Hospital In Chile
mTOR/P70S6K signaling pathway as a potential target for advanced gallbladder cancer therapy
Second-line FOLFOX chemotherapy in patients with metastatic gallbladder cancer and cholangiocarcinoma
The MCP-1/CCR2 Axis in the Biology of Acute Myeloid Leukemia: Possible Role in Blast Cell Migration
BONE MARROW STOMA SECRETES A SOLUBLE FACTOR THAT PROTECTS LEUKEMIA CELLS FROM CYTARABINE INDUCED APOPTOSIS BY BLOKING ENT ACTIVITY
Kinetics of human and marine mobilization of acute myeloid leukemia in response to AMD3100.

ConferencePaper (1)

The bone marrow stroma capacity to confer resistance to leukemia cells from Ara-C treatment as a prognostic factor for overall survival in AML.

ConferencePoster (1)

The bone marrow stroma as a novel prognostic factor for patients with acute myeloid leukaemia.

Patent (1)

Método ex vivo pronóstico y predictivo de respuesta de un cáncer al tratamiento con un agente antitumoral

Proyecto (15)

"Desarrollo de un test multigénico para pronóstico de LMA interrogando al estroma tumoral"
"The modulation of the leukemia-stroma interaction as a new strategy to improve outcomes in acute myeloid leukemia"
"Desarrollo de un test pronóstico para LMA interrogando por primera vez al estroma tumoral"
Desarrollo de un test predictivo de respuesta para leucemia mieloide aguda basado en la resistencia a quimioterapia conferida por el estroma de la médula ósea
The bone marrow stroma from acute myeloid leukemia patients secretes cytokines that protect leukemia cells from cytarabine induced apoptosis by modulation of human equilibrative nucleoside transporter-1
BM stroma from AML secretes cytokines that protect leukemia from cytarabine by modulation of hENT1
Plataforma de estudios preclinicos de xenotransplantes de tejidos metastasicos humanos para la evaluación de sensibilidad a drogas anticancerigenas.
The Bone Marrow Stromal Cells protect Acute Myeloid Leukemia from Cytarabine induced Apoptosis by the Activation of a Tyrosine Kinase Receptor
Instituto Milenio en Inmunología e Inmunoterapia
The Bone Marrow Stromal Cells protect Acute Myeloid Leukemia from Cytarabine induced Apoptosis by the Activation of a Tyrosine Kinase Receptor
Role of MCP-1/CCR2 Axis in the Survival and Progression of Acute Myeloid Leukemia
Preferential mobilization of leukemia precursors from the bone marrow into peripheral blood by the CXCR4 inhibitor AMD3100 in a mouse model
The interaction between leukemia and bone marrow stroma protects the tumor cells from drug induced apoptosis
A Phase I/II Study of MOZOBIL with Mitoxantrone, Etoposide and Cytarabine (AMD3100+MEC) in Relapsed or Refractory AML
La interacción entre leucemia y estroma de la médula ósea protege a las células tumorales de la apoptosis mediada por drogas

Review (4)

A snapshot of cancer in Chile: analytical frameworks for developing a cancer policy
Targeting specific molecular pathways holds promise for advanced gallbladder cancer therapy
Tratamiento y prevención de la mucositis oral asociada al tratamiento del cáncer
Treatment and prevention of cancer treatment related oral mucositis
60
Bruno Nervi

Associated Professor

Hematology - Oncology

Pontificia Universidad Catolica de Chile

Santiago, Chile

7
Juan Roa

Chair

Pathology

Pontificia Universidad Catolica de Chile

santiago, Chile

6
Helga Weber

Investigador

Vicerrectoría de Investigación y Post Grado

Universidad de la Frontera

Temuco, Chile

5
Verónica Jara

enfermera coordinadora

hematologia y oncologia

PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

santiago, Chile

5
Carolina Bizama

Profesor Asistente

Anatomía Patológica

PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

Santiago, Chile

5
Nicolas Jarufe

Chief Digestive Surgery

PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE

Santiago, Chile

5
Patricia García

Profesor Asistente Adjunto

ANATOMIA PATOLOGICA

PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

SANTIAGO, Chile

4
Cesar Sanchez

Profesor asistente

Hematologia-oncologia

PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

santiago, Chile

4
Francisco Acevedo

Medico Oncologo

Hemato Oncologia

Pontificia Universidad Católica de Chile

Santiago, Chile

4
Mauricio Pinto

Investigador

STORM SPA

Santiago, Chile

4
PAMELA LEAL

Profesor Asociado

Departamento de Ciencias Agronómicas y Recursos Naturales

UNIVERSIDAD DE LA FRONTERA

Temuco, Chile

4
Marcela Ferres

Head of Department

Pediatric Infectious Diseases and Immunology

Pontificia Universidad Católica de Chile

Santiago, Chile

4
Patricia Macanas

Profesor Asistente Adjunto

Hematology Oncology

PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

223543432, Chile

3
Francisco Aguayo

Profesor Asociado

Programa de Virología, Instituto de Ciencias Biomédicas (ICBM)

Universidad de Chile

Santiago, Chile

3
MAURICIO SARMIENTO

PROFESOR ASISTENTE

HEMATOLOGIA

PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

Santiago, Chile

3
Ismael Riquelme

Académico - Investigador

Ciencias de la Salud

UNIVERSIDAD AUTÓNOMA DE CHILE

Temuco, Chile

3
Daniel Ernst

Profesor Asistente

Hematología y Oncología

Pontificia Universidad Católica de Chile

Santiago, Chile

2
Alexis Kalergis

Full Professor

PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE. FACULTAD DE CIENCIAS BIOLÓGICAS

Santiago, Chile

2
MARCO ARRESE

FULL PROFESSOR

GASTROENTEROLOGY

PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE

Santiago, Chile

2
Erica Koch

Oncólogo Médico

Red de Salud UC Christus

Santiago, Chile

2
Lorena Rosa

PhD

Departamento de Patología

Pontificia Universidad Católica de Chile

Santiago, Chile

2
Miguel Cordova

Estudiando de Doctorado

Departamento de Posgrado

Universidad de Chile

Santiago, Chile

1
Bettina Müller

Jefe subrogante

Oncología Médica

Instituto Nacional del Cáncer

Santiago, Chile

1
Ricardo Armisen

Associate Professor

Centro de Genética y Genómica

Universidad del Desarrollo

Santiago, Chile

1
Marcelo Garrido

Director

CENTRO DEL CÁNCER, PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE

Santiago, Chile

1
ERICK RIQUELME

ASSISTANT PROFESSOR

ENFERMEDADES RESPIRATORIAS

Pontificia Universidad Católica de Chile

SANTIAGO, Chile

1
Fabian Tempio

Asistente de Investigación

Instituto de Ciencias Biomédicas

Universidad de Chile

Santiago, Chile

1
Carolina Ruiz

Medico Jefe UPC

Unidad de Paciente Crítico

Complejo Asistencial Sotero del Rio

Santiago, Chile

1
Ignacio Retamal

Docente

Universidad de Los Andes

Santiago, Chile

1
Sergio Vargas

Investigador

Hematología-Oncología

Pontificia Universidad Católica de Chile

Santiago, Chile

1
Leonardo Navarrete

Jefe de Laboratorio

Centro Internacional de Biomedicina

Santiago, Chile

1
Gareth Owen

Profesor Titular

Fisiologia

PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE

Santiago, Chile

1
Oslando Padilla

Estadístico

Salud Pública

PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE

Santiago, Chile

1
Luis González

Full Professor

School of Medicine

Universidad San Sebastián

Santiago, Chile

1
Juan Araya

Pathologist

Anatomía Patológica

Hospital Dr. Hernan Henríquez Aravena

Temuco, Chile

1
Cristian Falcón

Urólogo

Hospital San Juan de Dios

Santiago, Chile

1
Kurt Buchegger

Investigador Postdoctoral

Ciencias Básicas

Universidad de La Frontera

Temuco, Chile

1
Felipe Salech

Academic

Medicine

Universidad de Chile / Facultad de Medicina

Santiago, Chile

1
Gabriel Bastias

Profesor Asociado

Facultad de Medicina

Pontificia Universidad Católica de Chile

Santiago, Chile

1
Arnoldo Riquelme

Director UDA Ciencias de la Salud (Carreras de Nutrición y dietética, Fonoaudiología y Kinesiología)

Gastroenterología

Pontificia Universidad Católica de Chile

Santiago, Chile

1
Andrés Tittarelli

Investigador

Universidad Tecnológica Metropolitana

Santiago, Chile

1
Lorena Salazar

Academico

Instituto Cs Biomédicas

Universidad Autónoma de Chile

Santiago, Chile

1
María Maturana

Bioquimico

Pontificia Universidad Católica de Chile

Santiago, Chile

1
Pablo Muñoz

Profesor Asistente

Hematología-Oncología

Pontificia Universidad Católica de Chile

Santiago, Chile

1
EVA BUSTAMANTE

JEFE DE COORDINACION CIENTIFICA

INVESTIGACION Y DOCENCIA

FUNDACION ARTURO LOPEZ PEREZ

Santiago, Chile

1
FERNANDO CROVARI

Jefe Departamento

Cirugía Digestiva

Pontificia Universidad Católica de Chile

Santiago, Chile

1
Raquel Aguilera

PROFESOR ASISTENTE

INMUNOLOGÍA CLÍNICA Y REUMATOLOGÍA

PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

SANTIAGO, Chile

1
ALEJANDRO CORVALAN

Associate Professor

Hematology and Oncology

Pontificia Universidad Catolica de Chile

Santiago, Chile

1
Mercedes López

Profesora Asociada

Instituto de Ciencias Biomédicas

Universidad de chile

Santiago, Chile

1
Helena Poggi

Coordinadora de Investiagción

División de Pediatría

PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE

Santiago, Chile

1
Viviana Montecinos

Assistant Professor

Hematology Oncology

Pontificia Universidad Catolica de Chile

Santiago, Chile

1
Patricio Rojas

Hematólogo

Hematología-Oncología

Red de Salud UC-Christus

Santiago, Chile

1
jose valbuena

Associate Professor

Anatomic Pathology

PONTIFICIA UNIVERSIDAD CATOLICA. FACULTAD DE MEDICINA/ESCUELA DE MEDICINA/ DEPARTAMENTO DE ANATOMÍA PATOLÓGICA

santiago, Chile

1
Arnoldo Riquelme

Profesor titular

Gastroenterología

PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE, DEPARTAMENTO DE GASTROENTEROLOGÍA

Santiago, Chile

1
Felipe Bellolio

Cirujano coloproctólogo, Profesor Asistente

Cirugía Digestiva

Pontificia Universidad Católica de Chile

Santiago, Chile

1
Diego Catalán

Profesor Asistente

Programa Disciplinario de Inmunología

Universidad de Chile

Santiago, Chile

1
Carolina Selman

Subdirectora

Unidades de Diagnóstico

Fundación Arturo Lopez Perez

Santiago, Chile

1
Ana Guzman

MÉDICO JEFE LABORATORIO

LABORATORIO CLÍNICO

PONTIFICIA UNIVERSIDAD CATÓLICA

SANTAIGO, Chile